Effects of High Performance Inulin Supplementation on Glycemic Control and Antioxidant Status in Women with Type 2 Diabetes

Overview

Journal Diabetes Metab J

Specialty Endocrinology

Date 2013 May 4

PMID 23641355

Citations 39

Authors

Bahram Pourghassem Gargari

Parvin Dehghan

Akbar Aliasgharzadeh

Mohammad Asghari Jafar-Abadi

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of this study was to evaluate the effects of high performance inulin supplementation on blood glycemic control and antioxidant status in women with type 2 diabetes.

Methods: In a randomized, triple-blind controlled trial, 49 females (fiber intake <30 g/day, 25<body mass index <35 kg/m(2)) with type 2 diabetes were recruited from the Iran Diabetes Society and from endocrinology and metabolism clinics associated with the Tabriz University of Medical Science. The participants were divided into one of two groups in which the participants either received 10 g/day of inulin (intervention, n=24) or maltodextrin (control, n=25) for 2 months. Fasting blood samples were obtained and both glycemic control and antioxidant status were determined at baseline and at the end of the study.

Results: At the end of the study period, there were significant decreases in fasting plasma glucose (8.47%), glycosylated hemoglobin (10.43%), and malondialdehyde (37.21%) levels and significant increases in total antioxidant capacity (18.82%) and superoxide dismutase activity (4.36%) in the inulin group when compared to the maltodextrin group (P<0.05). Changes in fasting insulin, homeostasis model assessment of insulin resistance, and catalase activity were not significant in the inulin group when compared with the maltodextrin group. Glutathione peroxidase activity remained unchanged in both groups.

Conclusion: Inulin supplementation may improve some glycemic and antioxidant indices and decrease malondialdehyde levels in women with type 2 diabetes. Further investigations are needed in order to confirm the positive effects that inulin may have on the glycemic and antioxidant indices of patients with type 2 diabetes.

Citing Articles

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease.

Ciobarca D, Catoi A, Gavrilas L, Banc R, Miere D, Filip L Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006091 PMC: 11859434. DOI: 10.3390/ph18020279.

Daily intake of a dairy-based nutritional supplement improved self-reported gastrointestinal symptoms and modulated microbiota in adult Chinese volunteers.

Borewicz K, Zhao Y, Zhu Y Sci Rep. 2024; 14(1):28651.

PMID: 39562633 PMC: 11576911. DOI: 10.1038/s41598-024-79360-9.

Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes.

Iatcu O, Hamamah S, Covasa M Nutrients. 2024; 16(20).

PMID: 39458444 PMC: 11510484. DOI: 10.3390/nu16203447.

Effectiveness of Prebiotics and Mediterranean and Plant-Based Diet on Gut Microbiota and Glycemic Control in Patients with Prediabetes or Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Dimba N, Mzimela N, Sosibo A, Khathi A Nutrients. 2024; 16(19).

PMID: 39408238 PMC: 11478454. DOI: 10.3390/nu16193272.

The role of probiotics on the roadmap to a healthy microbiota: a symposium report.

Lockyer S, Aguirre M, Durrant L, Pot B, Suzuki K Gut Microbiome (Camb). 2024; 1:e2.

PMID: 39296722 PMC: 11406418. DOI: 10.1017/gmb.2020.2.

References

Russo I, Luciani A, De Cicco P, Troncone E, Ciacci C . Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One. 2012; 7(3):e32841. PMC: 3295784. DOI: 10.1371/journal.pone.0032841. View

Cherbut C . Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc. 2003; 62(1):95-9. DOI: 10.1079/PNS2002213. View

Baynes J . Role of oxidative stress in development of complications in diabetes. Diabetes. 1991; 40(4):405-12. DOI: 10.2337/diab.40.4.405. View

Tripathi B, Srivastava A . Diabetes mellitus: complications and therapeutics. Med Sci Monit. 2006; 12(7):RA130-47. View

Sheu W, Lee I, Chen W, Chan Y . Effects of xylooligosaccharides in type 2 diabetes mellitus. J Nutr Sci Vitaminol (Tokyo). 2008; 54(5):396-401. DOI: 10.3177/jnsv.54.396. View

Rishi P, Mavi S, Bharrhan S, Shukla G, Tewari R . Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiol Ecol. 2009; 69(2):222-30. DOI: 10.1111/j.1574-6941.2009.00703.x. View

Seidel C, Boehm V, Vogelsang H, Wagner A, Persin C, Glei M . Influence of prebiotics and antioxidants in bread on the immune system, antioxidative status and antioxidative capacity in male smokers and non-smokers. Br J Nutr. 2007; 97(2):349-56. DOI: 10.1017/S0007114507328626. View

Del Rio D, Pellegrini N, Colombi B, Bianchi M, Serafini M, Torta F . Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions. Clin Chem. 2003; 49(4):690-2. DOI: 10.1373/49.4.690. View

Gobinath D, Madhu A, Prashant G, Srinivasan K, Prapulla S . Beneficial effect of xylo-oligosaccharides and fructo-oligosaccharides in streptozotocin-induced diabetic rats. Br J Nutr. 2010; 104(1):40-7. DOI: 10.1017/S0007114510000243. View

10.

Franck A . Technological functionality of inulin and oligofructose. Br J Nutr. 2002; 87 Suppl 2:S287-91. DOI: 10.1079/BJNBJN/2002550. View

11.

Gourineni V, Verghese M, Boateng J, Shackelford L, Bhat K . Chemopreventive potential of synergy1 and soybean in reducing azoxymethane-induced aberrant crypt foci in fisher 344 male rats. J Nutr Metab. 2011; 2011:983038. PMC: 3062072. DOI: 10.1155/2011/983038. View

12.

Anderson J, Baird P, Davis Jr R, Ferreri S, Knudtson M, Koraym A . Health benefits of dietary fiber. Nutr Rev. 2009; 67(4):188-205. DOI: 10.1111/j.1753-4887.2009.00189.x. View

13.

Golozar A, Khademi H, Kamangar F, Poutschi H, Islami F, Abnet C . Diabetes mellitus and its correlates in an Iranian adult population. PLoS One. 2011; 6(10):e26725. PMC: 3203882. DOI: 10.1371/journal.pone.0026725. View

14.

Russo F, Riezzo G, Chiloiro M, De Michele G, Chimienti G, Marconi E . Metabolic effects of a diet with inulin-enriched pasta in healthy young volunteers. Curr Pharm Des. 2010; 16(7):825-31. DOI: 10.2174/138161210790883570. View

15.

Hassan H, Yousef M . Ameliorating effect of chicory (Cichorium intybus L.)-supplemented diet against nitrosamine precursors-induced liver injury and oxidative stress in male rats. Food Chem Toxicol. 2010; 48(8-9):2163-9. DOI: 10.1016/j.fct.2010.05.023. View

16.

Cani P, Knauf C, Iglesias M, Drucker D, Delzenne N, Burcelin R . Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes. 2006; 55(5):1484-90. DOI: 10.2337/db05-1360. View

17.

Luo J, Van Yperselle M, Rizkalla S, Rossi F, Bornet F, Slama G . Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr. 2000; 130(6):1572-7. DOI: 10.1093/jn/130.6.1572. View

18.

Bonsu N, Johnson C, McLeod K . Can dietary fructans lower serum glucose?. J Diabetes. 2010; 3(1):58-66. DOI: 10.1111/j.1753-0407.2010.00099.x. View

19.

Cani P, Delzenne N . The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009; 15(13):1546-58. DOI: 10.2174/138161209788168164. View

20.

Alles M, de Roos N, Bakx J, van de Lisdonk E, Zock P, Hautvast G . Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr. 1999; 69(1):64-9. DOI: 10.1093/ajcn/69.1.64. View